Skip to content
FY'25FY'24FY'23FY'22
Profitability
Gross margin28.6%+4.4pp24.2%-2.1pp26.3%-18.1pp44.4%-6.0pp
Operating margin-346.2%-38.2pp-308%-141pp-166.8%+72.6pp-239.4%-78.2pp
Net margin-341.5%-139pp-202.7%-49.8pp-153%+92.0pp-244.9%-106pp
Returns
Return on equity-213.5%-162pp-51.7%-3.2pp-48.5%-2.1pp-46.4%-14.2pp
Efficiency
Asset turnover0.2×+0.1×0.1×0.0×0.1×0.0×0.1×0.0×
Liquidity
Current ratio5.1×-2.3×7.5×-0.3×7.8×+4.6×3.2×-12.1×
Leverage
Debt-to-equity10.7×+10.6×0.0×0.1×-1.6×1.7×+0.5×
Per Share
Book value per share$0.02-99.0%$1.76-36.5%$2.77+10.3%$2.51-35.3%
Valuation
Market capitalization$496.96M+30.4%$538.6M-79.4%$2.62B+41.6%$1.85B-58.9%
Price / sales3.1×+0.6×3.5×-9.6×13.1×-1.4×14.4×-20.1×
Price / book210×+206×1.1×-2.7×3.7×+0.4×3.3×-2.4×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Pacific Biosciences of California's profit margins?
Pacific Biosciences of California (PACB) runs a 37.5% gross margin and a -83.3% operating margin, with a -80.3% net margin.
Where do Pacific Biosciences of California's ratios come from?
Every ratio is computed from Pacific Biosciences of California's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.